Results: 3

1.
Figure 2

Figure 2. Clinical Symptoms Over Time. From: Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Changes in Ham-D17 are plotted for the four groups (remitters and non-remitters on medication or placebo).

Ian A. Cook, et al. Psychiatry Res. ;174(2):152-157.
2.
Figure 3

Figure 3. Time Course of MRFC Change. From: Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Changes in MRFC at 48 hrs and 1 and 2 weeks of treatment, in subjects in remission (solid line with circles) and non-remission subjects (dashed line with squares) subjects. Groups show statistical separation at one and two weeks of exposure to medication. * p < 0.05

Ian A. Cook, et al. Psychiatry Res. ;174(2):152-157.
3.
Figure 1

Figure 1. Electrode Placements and Regions of Interest. From: Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Panel (a) shows the placement of 35 electrodes in accordance with the International 10–20 system; previously examined Region of Interest (ROI) included FP1, FPz, and FP2 electrodes (marked with asterisks). In Panel (b), the Midline and Right Frontal Cortical (MRFC) ROI includes Fpz, Fz, Fp2, AF2, F4, and F8 electrodes, outlined with black lines. Images depict the head from above.

Ian A. Cook, et al. Psychiatry Res. ;174(2):152-157.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk